Genital Wart Remover Cream

Description

No specific description details are available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the removal of genital warts, plantar warts, and flat warts. Common warts are characterized by their rough, "cauliflower-like" surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

Limitations of Use: There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. It is recommended to soak the wart in warm water for approximately 5 minutes to facilitate the process. After soaking, the area must be dried completely.

Using an applicator, such as a cotton swab, a layer of ointment should be applied to sufficiently cover each wart. It is important to allow the ointment to fully absorb into the skin. If necessary, the treated area may be covered with a bandage to protect it.

This procedure should be repeated once or twice daily as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Contact with eyes should be strictly avoided. In the event of exposure, it is imperative to flush the eye with water for 15 minutes to mitigate potential irritation or injury.

Inhalation of vapors is also contraindicated, as it may lead to respiratory discomfort or other adverse effects.

Warnings and Precautions

For external use only. It is imperative that healthcare professionals advise patients to keep the product away from fire and flame to prevent any potential hazards.

Contact with the eyes must be strictly avoided. In the event of accidental exposure, it is crucial to flush the eye with water for a minimum of 15 minutes to mitigate any adverse effects.

Inhalation of vapors should also be avoided, as this may lead to respiratory irritation or other complications.

To ensure the integrity of the product, it is recommended that the tube be capped tightly after each use.

Storage conditions are essential for maintaining product efficacy. The product should be stored out of direct sunlight and at room temperature, away from heat sources. Adhering to these precautions will help ensure safe and effective use of the product.

Side Effects

Patients should be advised that the product is for external use only. It is important to keep the product away from fire and flame to prevent any potential hazards.

No additional adverse reactions have been reported in clinical trials or postmarketing experiences.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Genital Wart Remover Cream (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. It is essential to ensure that the product is stored safely to prevent accidental ingestion or misuse. Caregivers must be vigilant in monitoring the storage of this medication to protect the health and safety of pediatric populations.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The safety of salicylic acid during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, which may include a risk of fetal harm if used during this period. Therefore, special precautions should be taken when considering the use of this product in pregnant individuals. Healthcare professionals are advised to weigh the potential benefits against the risks when prescribing salicylic acid to women of childbearing potential.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further research may be necessary to determine the safety profile in this population.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the available data. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of detailed information necessitates careful clinical judgment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, the use of antidotes or specific treatments should be considered based on the substance involved and the clinical presentation. Consultation with a poison control center or a medical toxicologist may provide additional guidance on the management of overdose cases.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to avoid contact with the eyes when using this product. In the event that the product does come into contact with the eyes, patients should be instructed to flush the eyes with water for at least 15 minutes.

Patients should also be cautioned against inhaling any vapors associated with the product to minimize respiratory irritation. It is important for patients to ensure that the tube is capped tightly after each use to maintain the integrity of the product.

Additionally, healthcare providers should inform patients about the proper storage conditions for the product. Patients should be advised to store the product out of direct sunlight and at room temperature, ensuring it is kept away from heat sources to preserve its effectiveness.

Storage and Handling

The product is supplied in a tube that must be capped tightly after each use to maintain its integrity. It is essential to store the product out of direct sunlight and at room temperature, ensuring it is kept away from heat sources.

Healthcare professionals should advise patients to keep the product out of reach of children to prevent accidental ingestion. Additionally, it is important to avoid contact with the eyes; in the event of exposure, the affected area should be flushed with water for 15 minutes. Care should also be taken to avoid inhaling vapors during handling.

Additional Clinical Information

The product is administered topically, with the recommended frequency being once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Genital Wart Remover Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)